Phase II study of amrubicin as second-line therapy in patients with platinum-refractory small-cell lung cancer

David S. Ettinger, Robert Jotte, Paul Lorigan, Vicram Gupta, Lawrence Garbo, Carlos Alemany, Paul Conkling, David R. Spigel, Arkadiusz Z. Dudek, Chirag Shah, Ravi Salgia, Richard McNally, Markus F. Renschler, Jennifer W. Oliver

Research output: Contribution to journalArticlepeer-review

105 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of amrubicin as second-line therapy in patients with platinum-refractory small-cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences